Answer:
Atypical antipsychotic drugs (APDs) increase dopamine (DA) release in prefrontal cortex (PFC), an effect probably mediated by the direct or indirect activation of the 5-HT1A receptor (5-HT1AR).
Answer:
schizophrenia
Explanation:
the dopamine hypothesis indicates hyperactive dopamine transmission results in schizophrenic symptoms.
